Moxetumomab pasudotox-tdfk Intravenous and Nepafenac Ophthalmic
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Nepafenac Ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: nepafenac ophthalmic
Brand name: Nevanac, Ilevro
Synonyms: Nepafenac
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-NephPlex RX
- Moxetumomab pasudotox-tdfk Intravenous-NephrAmine
- Moxetumomab pasudotox-tdfk Intravenous-NephrAmine 5.4%
- Moxetumomab pasudotox-tdfk Intravenous-Nephrocaps
- Moxetumomab pasudotox-tdfk Intravenous-Nephrocaps-QT
- Moxetumomab pasudotox-tdfk Intravenous-Nephron FA
- Nepafenac Ophthalmic-Moxifloxacin
- Nepafenac Ophthalmic-Moxifloxacin (Systemic)
- Nepafenac Ophthalmic-Moxifloxacin Hydrochloride
- Nepafenac Ophthalmic-Moxifloxacin Injection
- Nepafenac Ophthalmic-Moxifloxacin Intravenous
- Nepafenac Ophthalmic-Moxifloxacin Tablets